Michael W Miller

This inventor holds 47 USPTO granted patents and 11 EPO patents, primarily in Antidiabetic Compounds. Top assignees: Merck Sharp + Dohme Corp., Schering Corporation, Intervet Inc.. Active years: 2001-2022.

USPTO Granted Patents = 47

% Patents Active = 66.0

EPO Patents = 11 (Patent Applications = 9)

Average Co-Inventor Count = 3.8

ph-index = 6

Forward Citations = 213(Granted Patents)

Location History:

Westfield, NJ (US) (2001 - 2008)
Scotch Plains, NJ (US) (2006 - 2022)

Company Filing History:

23 out of 2,405

Merck Sharp + Dohme Corp.

Intervet International B.v.

patents

5. 1 out of 1

Merch Sharp & Dohne Corp. Rahway

where one patent can have more than one assignee

Years Active: 2001-2022

Loading Chart...

Areas of Expertise:

Antidiabetic Compounds

Bicyclic Compounds

Heterocyclic Compounds

Leucine-Rich Repeat Kinase

Glucagon Receptor Antagonists

Piperazine Derivatives

Piperidine Derivatives

CB1 Antagonists

CCR5 Antagonists

Spirochroman Compounds

Cyclopropyl Compounds

Imidazolones

47 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11225471 - Antidiabetic bicyclic compounds (2022-01-18),

2. 11180504 - Substituted carbapenems for the treatment of bacterial infections (2021-11-23),

3. 11072602 - Antidiabetic heterocyclic compounds (2021-07-27),

4. 10968232 - Antidiabetic spirochroman compounds (2021-04-06),

5. 10968193 - Antidiabetic bicyclic compounds (2021-04-06),

6. 10954240 - Compounds inhibiting leucine-rich repeat kinase enzyme activity (2021-03-23),

7. 10676458 - Antidiabetic bicyclic compounds (2020-06-09),

8. 10059667 - Antidiabetic compounds (2018-08-28),

9. 9957219 - Antidiabetic bicyclic compounds (2018-05-01),

10. 9840512 - Antidiabetic bicyclic compounds (2017-12-12),

11. 9809568 - Compounds inhibiting leucine-rich repeat kinase enzyme activity (2017-11-07),

12. 9718818 - Compounds inhibiting leucine-rich repeat kinase enzyme activity (2017-08-01),

13. 9688654 - Compounds inhibiting leucine-rich repeat kinase enzyme activity (2017-06-27),

14. 9493440 - Compounds inhibiting leucine-rich repeat kinase enzyme activity (2016-11-15),

15. 9440952 - Compounds inhibiting leucine-rich repeat kinase enzyme activity (2016-09-13),

Title: The Innovative Journey of Michael W Miller

Introduction: Michael W Miller, a distinguished inventor hailing from Westfield, NJ, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Michael W Miller's latest patents include a cutting-edge software application for data encryption, a revolutionary medical device for remote patient monitoring, and an advanced algorithm for autonomous vehicle navigation.

Career Highlights: With over two decades of experience in the tech industry, Michael W Miller has a proven track record of developing innovative solutions. He has held key positions in renowned tech companies, leading teams to create cutting-edge products that have shaped the industry.

Collaborations: Throughout his career, Michael W Miller has collaborated with top researchers, engineers, and designers to bring his inventions to life. His ability to work in multidisciplinary teams has resulted in the successful development and commercialization of several groundbreaking technologies.

Conclusion: Michael W Miller's passion for innovation and his dedication to pushing the boundaries of technology have established him as a prominent figure in the world of inventors. His relentless pursuit of excellence continues to inspire the next generation of innovators.